Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$32.77 - $42.31 $99,424 - $128,368
3,034 Added 26.77%
14,367 $600,000
Q3 2023

Nov 13, 2023

BUY
$35.46 - $40.13 $401,868 - $454,793
11,333 New
11,333 $427,000
Q3 2020

Nov 12, 2020

SELL
$54.41 - $68.2 $305,947 - $383,488
-5,623 Closed
0 $0
Q2 2020

Aug 13, 2020

SELL
$61.66 - $70.16 $40,202 - $45,744
-652 Reduced 10.39%
5,623 $374,000
Q1 2020

May 13, 2020

BUY
$59.35 - $88.73 $29,675 - $44,365
500 Added 8.66%
6,275 $0
Q4 2019

Feb 12, 2020

SELL
$74.18 - $97.92 $126,106 - $166,464
-1,700 Reduced 22.74%
5,775 $508,000
Q3 2019

Nov 13, 2019

BUY
$75.36 - $86.57 $88,548 - $101,719
1,175 Added 18.65%
7,475 $564,000
Q2 2019

Aug 07, 2019

SELL
$83.92 - $108.88 $54,548 - $70,772
-650 Reduced 9.35%
6,300 $538,000
Q1 2019

May 08, 2019

SELL
$85.97 - $108.09 $221,372 - $278,331
-2,575 Reduced 27.03%
6,950 $751,000
Q4 2018

Feb 12, 2019

SELL
$78.25 - $107.92 $305,175 - $420,888
-3,900 Reduced 29.05%
9,525 $806,000
Q3 2018

Nov 13, 2018

BUY
$97.82 - $116.09 $66,028 - $78,360
675 Added 5.29%
13,425 $1.32 Million
Q2 2018

Aug 02, 2018

BUY
$97.62 - $120.59 $1.24 Million - $1.54 Million
12,750 New
12,750 $1.48 Million

Others Institutions Holding TARO

About TARO PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TARO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 37,584,600
  • Description
  • Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...
More about TARO
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.